Imagenetix, Inc. Stock

Equities

IAGX

US45247F1049

Food Processing

Market Closed - OTC Markets 03:39:02 2023-06-30 pm EDT 5-day change 1st Jan Change
0.0002 USD +100.00% Intraday chart for Imagenetix, Inc. -.--% -.--%
Sales 2010 6.6M Sales 2011 7.13M Capitalization 6.22M
Net income 2010 - Net income 2011 -2M EV / Sales 2010 0.45 x
Net cash position 2010 982K Net Debt 2011 740K EV / Sales 2011 0.72 x
P/E ratio 2010
-5.69 x
P/E ratio 2011
-1.95 x
Employees -
Yield 2010 *
-
Yield 2011
-
Free-Float 36.25%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0.0002
0.00
3 years
0.00
Extreme 0
0.02
5 years
0.00
Extreme 0
0.02
10 years
0.00
Extreme 0
0.49
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15-10-20
Director of Finance/CFO 78 05-06-30
Chief Tech/Sci/R&D Officer 71 98-12-31
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer 71 98-12-31
Chief Executive Officer - 15-10-20
More insiders
Imagenetix, Inc. develops, formulates, markets over-the-counter, natural-based nutritional supplements and skin care products. The Company's products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Its primary product is Celadrin, a product formulation, which it sells to the mass market through retailers and on a private label basis to wholesale customers. The Company licenses its intellectual property to third parties. It is focused on two medical need areas, which include human and animal conditions related to inflammation and obesity. It has researched and developed active compositions in the areas of joint health, arthritis and periodontal disease, among others. The Company sells its own branded product, Celadrin, directly to the mass markets through retail sellers. It also offers Celadrin products through wholesale customers.
More about the company